made in the United States), arabic gum, citric acid, flavoring], hydroxypropylmethylcellulose, milk thistle extract powder (made in the United States), -cyclodextrin, glycerin, flavoring (natural lemon), other edible oil and vegetable products, vitamin E, giza yellow pigment, polysorbate 80, L-cysteine hydrochloride, citric acid, modified starch milk
Confusingly, the December 2024 South African package insert states the following: This reduction in exposure after a single dose of MOUNJARO is not considered clinically relevant
Cardiovascular and Metabolic Benefits Although not yet conclusively proven, early data suggest that Tirzepatide may: Improve blood pressure and lipid profiles Reduce markers of inflammation and insulin resistance Potentially lower cardiovascular risk, though large outcome trials like SURPASS-CVOT are underway to confirm this Such benefits are particularly relevant, as cardiovascular disease is the leading cause of death among people with type 2 diabetes
Every four weeks, your healthcare professional will increase the dose until you reach your maintenance dose of either 1.7 mg or 2.4 mg once weekly
Yes, many patients switch between formats under the guidance of a healthcare provider
These serve as messengers to the body and instruct the cells to carry out specific actions such as repairing tissue, synthesizing collagen, or triggering growth
